FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1.
about
Haematopoietic protein tyrosine phosphatase (HePTP) phosphorylation by cAMP-dependent protein kinase in T-cells: dynamics and subcellular locationInhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinaseDifferential effects of hyperphosphorylation on splicing factor SRp55Roles of bioactive sphingolipids in cancer biology and therapeuticsThe Role of Alternative Splicing in the Control of Immune Homeostasis and Cellular DifferentiationActivation and localization of inositol phosphosphingolipid phospholipase C, Isc1p, to the mitochondria during growth of Saccharomyces cerevisiae.The structural requirements for ceramide activation of serine-threonine protein phosphatasesAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedCeramide induced mitophagy and tumor suppressionPrimary cilia in stem cells and neural progenitors are regulated by neutral sphingomyelinase 2 and ceramide.Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells.Cell signalling and the control of pre-mRNA splicing.Interplay between estrogen receptor and AKT in estradiol-induced alternative splicingLysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.Utilization of host SR protein kinases and RNA-splicing machinery during viral replicationCeramide: second messenger or modulator of membrane structure and dynamics?C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia.SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cellsProtein phosphatase 2A and neutral sphingomyelinase 2 regulate IRAK-1 protein ubiquitination and degradation in response to interleukin-1betaMicrocystin-LR and okadaic acid-induced cellular effects: a dualistic response.Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1.The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma CellsProtein kinase C-dependent control of Bcl-x alternative splicing.Sphingolipids: regulators of crosstalk between apoptosis and autophagyCombined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.Confluence induced threonine41/serine45 phospho-beta-catenin dephosphorylation via ceramide-mediated activation of PP1cgamma.Identification and characterization of protein phosphatase 2C activation by ceramide.Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathwayCeramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cellsFunctional interplay between viral and cellular SR proteins in control of post-transcriptional gene regulation.Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis.Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistanceRegulation of ceramide channel formation and disassembly: Insights on the initiation of apoptosis.Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis.Alternative splicing and cell survival: from tissue homeostasis to disease.
P2860
Q24299601-924CC775-EC6E-4414-9702-29430C78F1B6Q24314907-822702D9-21E4-4599-90EB-E8DFE744D9A9Q24529916-85DE1120-9195-4213-9B90-99F0760D137BQ24657499-00F1DE31-A664-4403-88FB-C56AE86A28D4Q26772026-9C7FA25F-F6C1-443B-BBED-44A2CF78C790Q27936441-BA030D95-8E75-4A54-B49B-3CBE1762BC2CQ28189436-80B4317A-68AA-4001-B60C-2391881514D5Q28297381-BE1ED78E-F8E5-4B55-AF2C-B8965CF12BF8Q28384389-6FBF3F7D-C3B1-45EF-95F1-64AB32CA6C1BQ33685638-BA86B5A9-F367-4276-967C-BAB758949923Q33800261-3367EAFD-A68C-4071-9494-6DDAA9D288CDQ34302149-05E40280-D07B-4C62-99D5-6224D723CA24Q34550567-5815E43E-AA40-47AE-8401-EB249ACC3CBEQ34768156-101BF55F-7E1C-46CD-A59F-44EFAC917617Q34955984-7D9E33F8-E31D-4113-99DB-A3EDCA06E89AQ34983999-646792E3-08C2-410D-92BA-626464CFB7FBQ34984863-AD190FC1-6E4E-4F03-98F2-0B98BFC29229Q35075838-891B411B-82EE-448A-A0E6-AFF13F4E0415Q35118687-90F32ABD-0137-41D6-957E-D074294F700EQ35213446-D0016E0E-8E04-4AD1-9B59-A2789A029BE5Q35637404-9DDE84C1-54A1-4186-A2A7-5B04658C9179Q35805025-3BBA5698-3A33-46FB-B06A-B7FDF3C9AD8AQ35955993-3A4DD372-1C12-49B4-82CE-74B030EF3048Q35973562-64E0D344-95BA-4B4E-9D53-4E188EF0E540Q36134202-EA5E8A69-5E6D-4EA4-B9F7-1AF7517DD578Q36316498-21CBEEF9-EA11-402A-A159-63B5B0C006E2Q36462123-58569977-C5CA-45F8-82BC-3563E3389AFAQ36501180-12AB7EBF-1F25-4D2F-8526-FECC6BABEF72Q36514631-A13C1068-B0AE-49CF-B7EC-F14AB510FE5DQ36520332-F0D7F418-2971-45DB-80D0-57666017858CQ36562936-82991FEF-FCA8-4F76-8C38-FA42410D875FQ37147627-78AC69B3-7B60-4164-8763-0FC19082760EQ37394282-5F29B67E-1228-4117-B4B9-D3E25C358454Q37718254-2F4E703B-17BE-4FA7-BCEA-31E04DEB186AQ37808219-FA5C5269-5517-4667-BBF6-6EF756A16295Q37874939-E3BADB4B-F6D6-4AEB-A64B-46FD35D46F1EQ38195691-0B291CDC-38DB-43D0-A408-E40B949638E8Q38639669-1EDA026F-44CF-4F44-8ED8-3EFC583EE3A2Q38889429-EB568D8A-CA8D-4E9B-8EE5-26951BEA3B26Q38968877-08C48CE0-7440-4D8D-9CA1-2F4EFC519FAB
P2860
FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
FAS activation induces dephosp ...... tion of protein phosphatase 1.
@en
type
label
FAS activation induces dephosp ...... tion of protein phosphatase 1.
@en
prefLabel
FAS activation induces dephosp ...... tion of protein phosphatase 1.
@en
P2093
P356
P1476
FAS activation induces dephosp ...... tion of protein phosphatase 1.
@en
P2093
B J Kroesen
B J Pettus
B Ogretmen
C E Chalfant
S Galadari
Y A Hannun
P304
44848-44855
P356
10.1074/JBC.M106291200
P407
P577
2001-08-13T00:00:00Z